Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Anastasiia Sosyniuk Shares AI Visibility Playbook for HealthTech Innovators at Vitalis 2026
EIN Presswire
Session Explores How HealthTech Organizations Can Build Authority and Earn Citations in AI-Generated Search Results GOTHENBURG, GOTHENBURG, SWEDEN, June 12, 2026 /EINPresswire.com/ -- May 2026 Anastasiia Sosyniuk, co-founder of Go Global and an...
Evaxion receives Prix Galien UK Award for Best digital health solution
GlobeNewswire, Inc.
COPENHAGEN, Denmark, June 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, has been awarded the 2026 Prix Galien UK Award for Best digital...
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio
GlobeNewswire, Inc.
Doc Pharma financial profile: approximately $24 million asset base, approximately $6.7 million in average annual revenue and approximately $3.2 million in average annual gross profit.
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
GlobeNewswire, Inc.
Southlake, TX, June 11, 2026 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT”) company focused on advancing electrocardiography (“ECG” or “EKG”) through the...
EU Reaches Deal to Strengthen Defense Industry, Speed Up Investment
MENAFN
(MENAFN) Negotiators from the EU Council and the European Parliament have reached a provisional agreement on a broad reform package aimed at strengthening Europe’s defense industry and improving military readiness by reducing bureaucratic barriers...
Competition in the Healthcare Claims Management Solutions Market: Growth Strategies of Top Companies
EIN Presswire
The Business Research Company's Competition in the Healthcare Claims Management Solutions Market: Growth Strategies of Top Companies LONDON, GREATER LONDON, UNITED KINGDOM, June 11, 2026 /EINPresswire.com/ -- "The healthcare claims management...
Cosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Compliance
GlobeNewswire, Inc.
Extension granted through December 7, 2026 Reflects the Company's compliance with all other applicable Nasdaq listing requirements.
KFSH Advances Practical AI Applications Driving Transformation Across Specialized Healthcare
GlobeNewswire, Inc.
RIYADH, Saudi Arabia, June 11, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH) will highlight its practical applications of artificial intelligence during its participation at HLTH Europe 2026, taking place from...
LOTTE HOLDINGDS Healthcare and Biopharmaceutical CVC Announces Investment in ClearideBio Therapeutics
EIN Presswire
TOKYO, JAPAN, June 11, 2026 /EINPresswire.com/ -- LOTTE HOLDINGDS, CO., LTD. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE HOLDINGDS”) announces an investment in ClearideBio Therapeutics AG (hereinafter, “ClearideBio”), an...
KFSH Advances Practical AI Applications Driving Transformation Across Specialized Healthcare
EIN Presswire
RIYADH, SAUDI ARABIA, June 11, 2026 /EINPresswire.com/ -- King Faisal Specialist Hospital & Research Centre (KFSH) will highlight its practical applications of artificial intelligence during its participation at HLTH Europe 2026, taking place...
ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
GlobeNewswire, Inc.
In first line AML (ALICE-2 trial), iadademstat with azacitidine and venetoclax showed high levels of clinical activity, with 100% (18/18) ORR, 89% (16/18) CRc and 78% (14/18) CR, and continued to demonstrate a favorable safety profile All patients...
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
GlobeNewswire, Inc.
-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-naïve patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case study of a patient who previously received an...
Global Next Generation Sequencing Services Market Size/Share Worth USD 56.1 Billion by 2035 at a 23.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, June 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Next Generation Sequencing Services Market Size, Trends and Insights By Service Type (Human Genome Sequencing Services, Microbial...
Naqi Logix Showcases the Future of AI-Neurotechnology at Europe’s VivaTech 2026
EIN Presswire
Naqi's non-invasive AI neural earbuds transform biosignals into seamless hands-free, voice-free, screen-free control of computers, robotics, & connected devices VANCOUVER, BC, CANADA, June 11, 2026 /EINPresswire.com/ -- Naqi Logix Inc. ("Naqi"...
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population
GlobeNewswire, Inc.
At the 100 µg Recommended Phase 2 Dose (RP2D), Cemsidomide Demonstrated a 53% Overall Response Rate, Including Complete Responses and Minimal Residual Disease (MRD) Negative Status Cemsidomide Was Well Tolerated With Minimal Discontinuations and...
Casein and Caseinate Market Expands to US$6.2 Bn Driven by Sports Nutrition
EIN Presswire
The casein and caseinate market is projected to grow steadily from US$ 3.8 Bn in 2026 to US$ 6.2 Bn by 2033, registering a CAGR of 5.6% overall LONDON, LONDON, UNITED KINGDOM, June 11, 2026 /EINPresswire.com/ -- The global casein and caseinate...
Oriva Therapeutics appoints Dr Agnès Arbat as CEO to advance clinical-stage women’s health pipeline
GlobeNewswire, Inc.
Oriva is developing innovative medicines for chronic gynaecological diseases and is backed by pre-seed financing from Asabys Partners’ Sabadell Asabys II fund Dr Arbat brings over 25 years’ pharma industry experience, including roles in women’s...
EU Reports Thousands of Drug Overdose Deaths in 2024
MENAFN
(MENAFN) A newly released European drug assessment has revealed that at least 7,600 people lost their lives to drug overdoses across the European Union in 2024, while warning of growing concerns linked to the availability and evolution of illicit...
European Nations Raise Alarm Over Israeli NGO Law's Impact on Aid Efforts
MENAFN
(MENAFN) A coalition of 22 countries along with senior European officials has expressed strong concern over a recent Israeli court ruling that upheld a disputed law governing the registration of international non-governmental organizations,...
![[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/af9c6fb4-2b61-4367-852e-7237ba1d9bc4/north-america-gastrointestinal-endoscopy-devices-market-size-2025-to-2035-usd-billion-.png)
[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
GlobeNewswire, Inc.
Austin, TX, USA, June 11, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Gastrointestinal Endoscopy Devices Market Size, Trends and Insights By Type (Rigid Gastrointestinal Endoscopes, Flexible...
Sign up for:
Healthy Living Europe
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.